on NANOBIOTIX (EPA:NANO)
Voting Rights and Share Capital Update by Nanobiotix
On July 30, 2026, Nanobiotix, a prominent biotechnology firm, released an update regarding its voting rights and share capital. As of June 30, 2026, the company reports a total of 50,825,682 shares outstanding. These shares correspond to 54,486,890 theoretical voting rights and 54,464,772 exercisable voting rights. This update aligns with the French Commercial Code and regulations of the Autorité des Marchés Financiers.
Nanobiotix is listed both on Euronext Paris and the Nasdaq Global Select Market. The company actively engages in pioneering treatments using physics-based therapeutic approaches, potentially benefiting a vast number of patients globally. For further details, stakeholders are encouraged to visit their official website or contact the investor or media relations teams.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news